Science Explorer Back to mapMap

Most cited papers from Allergy Associates Research Center

What are the most cited papers from Allergy Associates Research Center?

The most cited paper from Allergy Associates Research Center is "Development of the asthma control test" (Robert A. Nathan, Christine A. Sorkness, Mark R. Kosinski et al., 2004), with 2,939 citations. Next come "Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists" (1,235) and "Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies" (382).

Showing 50 of 60 papers. Every paper with more than 74 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Development of the asthma control test Robert A. Nathan, Christine A. Sorkness, Mark R. Kosinski et al. · Journal of Allergy and Clinical Immunology 2004 2,939
2 Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists Michael N. Schatz, Christine A. Sorkness, James T. Li et al. · Journal of Allergy and Clinical Immunology Mar 2006 1,235
3 Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies Nicola Alexander Hanania, Michael James Noonan, Jonathan Corren et al. · Thorax Open access 22 May 2015 382
4 Absence of Growth Retardation in Children With Perennial Allergic Rhinitis After One Year of Treatment With Mometasone Furoate Aqueous Nasal Spray Eric J. Schenkel, David P. Skoner, Edwin A. Bronsky et al. · PEDIATRICS Feb 2000 357
5 Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks Aleena Banerji et al. · JAMA Open access 27 Nov 2018 310
6 Antimicrobial Peptides Human β-Defensins and Cathelicidin LL-37 Induce the Secretion of a Pruritogenic Cytokine IL-31 by Human Mast Cells François Niyonsaba, Hiroko Ushio, Mutsuko Hara et al. · The Journal of Immunology 26 Feb 2010 282
7 Predicting Response to Omalizumab, an Anti-IgE Antibody, in Patients With Allergic Asthma Jean Bousquet, Sally E. Wenzel, Stephen T. Holgate et al. · CHEST Journal Apr 2004 278
8 Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities Nicole Frahm et al. · Journal of Virology Open access 12 Feb 2004 276
9 Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder—A Randomized, Controlled 12-Month Trial James B. Adams, TAPAN K. AUDHYA, Elizabeth Geis et al. · Nutrients Open access 17 Mar 2018 273
10 Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients C.-G. Löfdahl, T.F. Reiss, Jared A. Leff et al. · BMJ Open access 10 Jul 1999 267
11 Broad Specificity of Virus-Specific CD4+T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection Cheryl L. Day, Georg Michael Lauer, Gregory K. Robbins et al. · Journal of Virology Open access 18 Nov 2002 257
12 NC/Nga Mice: A Mouse Model for Atopic Dermatitis Hajime Suto, Hiroshi Matsuda, Koichi Mitsuishi et al. · International Archives of Allergy and Immunology 1999 250
13 Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor Hilary J Longhurst et al. · New England Journal of Medicine Open access 22 Mar 2017 238
14 Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans Fabio Candotti et al. · Blood Open access 13 Sep 2012 236
15 Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial William R. Lumry, H. Henry Li, Robyn J. Levy et al. · Annals of Allergy Asthma & Immunology 10 Oct 2011 229
16 Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes Julian Schulze zur Wiesch, Georg Michael Lauer, Cheryl L. Day et al. · The Journal of Immunology Sep 2005 191
17 Assessing Future Need for Acute Care in Adult Asthmatics Molly L. Osborne, Kathryn L. Pedula, Mark T. O’Hollaren et al. · CHEST Journal 16 Jun 2007 186
18 Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities Georg Michael Lauer, Kei Ouchi, Raymond T. Chung et al. · Journal of Virology Open access 15 Jun 2002 185
19 Omalizumab is effective in the long-term control of severe allergic asthma Bobby Quentin Lanier, Jonathan Corren, William R. Lumry et al. · Annals of Allergy Asthma & Immunology Aug 2003 185
20 Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance ofgagandnefand the Presence of Broadly Recognized Peptides Daniel E. Kaufmann, Paul M Bailey, John Sidney et al. · Journal of Virology Open access 12 Apr 2004 179
21 Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human α-defensins from neutrophils Yan Zheng, François Niyonsaba, Hiroko Ushio et al. · British Journal of Dermatology 4 Oct 2007 178
22 Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group M.J. Noonan, Paul Chervinsky, M. Brandon et al. · European Respiratory Journal Open access Jun 1998 176
23 Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids Michael James Noonan, Phillip E. Korenblat, Sofia Mosesova et al. · Journal of Allergy and Clinical Immunology 29 May 2013 172
24 Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial Stephen T. Holgate, Michael James Noonan, Pascal Chanez et al. · European Respiratory Journal Open access 25 Nov 2010 167
25 The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma Roland Buhl, Gerald Hanf, Mauricio Ruiz Soler et al. · European Respiratory Journal Open access Nov 2002 160
26 Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial Jennifer M. Maloney, David I. Bernstein, Harold S. Nelson et al. · Annals of Allergy Asthma & Immunology 21 Dec 2013 158
27 Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device Frank C. Hampel, Paul H. Ratner, Julius van Bavel et al. · Annals of Allergy Asthma & Immunology Aug 2010 155
28 Cross-Reactivity of Plant and Animal Allergens Richard W. Weber · Clinical Reviews in Allergy & Immunology 2001 154
29 Childhood Obesity and Asthma Control in the GALA II and SAGE II Studies Luisa N. Borrell, Elizabeth A. Nguyen, Lindsey A. Roth et al. · American Journal of Respiratory and Critical Care Medicine Open access 8 Feb 2013 144
30 Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis Paul H. Ratner, Frank C. Hampel, Julius van Bavel et al. · Annals of Allergy Asthma & Immunology 2008 135
31 Cytotoxicity Assessment of Some Carbon Nanotubes and Related Carbon Nanoparticle Aggregates and the Implications for Anthropogenic Carbon Nanotube Aggregates in the Environment Lawrence E. Murr, Kristine M. Garza, K. F. Soto et al. · International Journal of Environmental Research and Public Health Open access 30 Apr 2005 133
32 Drug‐Induced Sleep Endoscopy and Surgical Outcomes: A Multicenter Cohort Study Katherine K. Green, David T. Kent, Mark A. D׳Agostino et al. · The Laryngoscope Open access 27 Dec 2018 131
33 The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients Sandra M. Gawchik, Consuelo L. Saccar, Michael James Noonan et al. · Journal of Allergy and Clinical Immunology Open access Apr 1999 128
34 Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma Stanley James Szefler, James Baker, Tom Uryniak et al. · Journal of Allergy and Clinical Immunology Nov 2007 120
35 Nasal Airway Obstruction: Prevalence and Anatomic Contributors David W. Clark, Anthony G. Del Signore, Roheen Raithatha et al. · Ear Nose & Throat Journal Open access Jun 2018 116
36 Effects of montelukast and beclomethasone on airway function and asthma control Elliot Israel, Paul Chervinsky, Bruce F. Friedman et al. · Journal of Allergy and Clinical Immunology Open access Dec 2002 114
37 Remibrutinib in Chronic Spontaneous Urticaria Martin Metz, A.M. Giménez-Arnau, Michihiro Hide et al. · New England Journal of Medicine 5 Mar 2025 111
38 Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study Aleena Banerji, Jonathan A. Bernstein, Douglas T Johnston et al. · Allergy Open access 21 Jul 2021 108
39 Vpr Is Preferentially Targeted by CTL During HIV-1 Infection Marcus A. Altfeld, Marylyn M. Addo, Robert L. Eldridge et al. · The Journal of Immunology Sep 2001 107
40 Current state of hereditary angioedema management: A patient survey Aleena Banerji, Paula Jane Busse, Sandra C. Christiansen et al. · Allergy and Asthma Proceedings Open access May 2015 104
41 The Human Cathelicidin LL-37 Host Defense Peptide Upregulates Tight Junction-Related Proteins and Increases Human Epidermal Keratinocyte Barrier Function Toshihiro Akiyama, François Niyonsaba, Chanisa Kiatsurayanon et al. · Journal of Innate Immunity Open access 2014 104
42 Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent Viruses Georg Michael Lauer, Tam Nguyen, Cheryl L. Day et al. · Journal of Virology Open access 15 Mar 2002 104
43 Portable flanking sequences modulate CTL epitope processing Sylvie Le Gall, Pamela Stamegna, Bruce D. Walker · Journal of Clinical Investigation Open access Nov 2007 102
44 Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema William R. Lumry, Timothy Craig, Bruce L. Zuraw et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 31 Jan 2018 101
45 Tumor-on-a-chip: a microfluidic model to study cell response to environmental gradients José María Ayuso, Marı́a Virumbrales-Muñoz, Patrick H. McMinn et al. · Lab on a Chip Open access 2019 98
46 Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies Mark R. Stein, Robert P. Nelson, Joseph A. Church et al. · Journal of Clinical Immunology Open access 23 Sep 2008 96
47 Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study Brian P. Vickery et al. · The Journal of Allergy and Clinical Immunology In Practice Open access 24 Dec 2020 93
48 Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler Michael James Noonan, Jill P. Karpel, George W. Bensch et al. · Annals of Allergy Asthma & Immunology 2001 93
49 Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler David I. Bernstein et al. · Respiratory Medicine Open access Sep 1999 92
50 Immunological and Virological Impact of Highly Active Antiretroviral Therapy Initiated during Acute HIV‐1 Infection Hendrik Streeck, Heiko K. Jessen, Galit Alter et al. · The Journal of Infectious Diseases Open access 22 Aug 2006 90

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.